metricas
covid
Annals of Hepatology Most cited
Journal Information

Most cited

Data available in articles published since the year 2014

115
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
115
Open access
79
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
79
Open access
56
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
Pegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
56
Open access
51
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
51
Open access
35
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis
Yesmi A. Ortega Rojas, Claudia L. Vidal Cuellar, Karina M. Aparicio Barrón, Juan Pablo Arab, Adelina Lozano Miranda
Ann Hepatol. 2022;27:100706
35
Full text access
33
Acid-base abnormalities and liver dysfunction
Periklis Katopodis, Efthymios M. Pappas, Konstantinos P. Katopodis
Ann Hepatol. 2022;27:100675
33
Full text access
32
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway
Si-Si Jin, Chun-Jing Lin, Xian-Fan Lin, Ju-Zeng Zheng, Hua-Qin Guan
Ann Hepatol. 2022;27:100584
32
Full text access
31
Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy
Tianyi Liang, Yongfei He, Shutian Mo, Zijun Chen, Xiwen Liao, Xin Zhou, Chengkun Yang, Shuqi Zhao, ... Tao Peng
Ann Hepatol. 2022;27:100695
31
Open access
30
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Víctor Tsutsumi, Pablo Muriel
Ann Hepatol. 2022;27:100671
30
Full text access
29
Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis
Wu Shu, Chen Shanjian, Lin Jinpiao, Ou Qishui
Ann Hepatol. 2022;27:100676
29
Full text access